Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
- Publikationstyp
Publikationstyp- Sprache
- Datenbank
-
1
von Ridker P.M. ; Everett B.M. ; Thuren T. ; et al.
New England Journal of Medicine
Schlagworte: C reactive protein; canakinumab; placebo; antiinflammatory agent; interleukin 1beta; lipid; monoclonal antibody; adult; Article; atherosclerosis; bleeding; cardiovascular mortality; cardiovascular parameters; cellulitis; clinical effectiveness; controlled study; double blind procedure; drug dose comparison; drug safety; female; follow up; gout; heart infarction; human; incidence; infection; injection site reaction; leukopenia; major clinical study; male
-
2
von Ridker PM ; Everett BM ; Thuren T ; et al.
Schlagworte: Antiinflammatory Therapy; Canakinumab; for Atherosclerotic Disease
-
3
von Ridker, P ; Everett, B ; Thuren, T ; et al.
Schlagworte: C reactive protein; canakinumab; placebo; antiinflammatory agent; interleukin 1beta; lipid; monoclonal antibody; info:eu-repo/semantics/article
-
4
von Ridker P.M. ; Everett B.M. ; Thuren T. ; et al.
New England Journal of Medicine
Schlagworte: C reactive protein; canakinumab; placebo; antiinflammatory agent; interleukin 1beta; lipid; monoclonal antibody; adult; Article; atherosclerosis; bleeding; cardiovascular mortality; cardiovascular parameters; cellulitis; clinical effectiveness; controlled study; double blind procedure; drug dose comparison; drug safety; female; follow up; gout; heart infarction; human; incidence; infection; injection site reaction; leukopenia; major clinical study; male; malignant neoplasm; neutropenia; opportunistic infection; osteoarthritis; outcome assessment; pneumonia; priority journal; pseudomembranous colitis; randomized controlled trial; sepsis; thrombocytopenia; toxic hepatitis; treatment outcome; treatment response; tuberculosis; urinary tract infection; aged; antagonists and inhibitors; blood; Cardiovascular Diseases; chemically induced; clinical trial; dose response; immunology; metabolism; middle aged; mortality; multicenter study; Myocardial Infarction; secondary prevention; Stroke; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Atherosclerosis; C-Reactive Protein; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Incidence; Infection; Interleukin-1beta; Lipids; Male; Middle Aged; Neutropenia; Secondary Prevention; Article
-
5
von Ridker P.M. ; Everett B.M. ; Thuren T. ; et al.
New England Journal of Medicine
Schlagworte: C reactive protein; canakinumab; placebo; antiinflammatory agent; interleukin 1beta; lipid; monoclonal antibody; adult; Article; atherosclerosis; bleeding; cardiovascular mortality; cardiovascular parameters; cellulitis; clinical effectiveness; controlled study; double blind procedure; drug dose comparison; drug safety; female; follow up; gout; heart infarction; human; incidence; infection; injection site reaction; leukopenia; major clinical study; male
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag